Mitchell Steiner
Algemeen Directeur bij VERU INC.
Vermogen: 7 M $ op 31-05-2024
Profiel
Mitchell Shuster Steiner is the founder of GTx, Inc., which was founded in 1997.
He held the title of Vice Chairman, Chief Executive Officer & CSO from 2011 to 2012.
He is also the founder of Aspen Park Pharmaceuticals, Inc., which was founded in 2014.
He held the title of Vice Chairman, President & Chief Executive Officer from 2014 to 2016.
Currently, Dr. Steiner is the Chairman, President & Chief Executive Officer at Veru, Inc. since 2016.
He is also a Director at The Female Health Company (UK) Plc and Mezzion Pharma Co., Ltd.
In the past, Dr. Steiner worked as a Professor at the University of Tennessee from 1995 to 2004.
He was the President-Urology at OPKO Health, Inc. from 2014 to 2016.
He also served as an Assistant Professor at Vanderbilt University School of Medicine from 1993 to 1995.
Dr. Steiner obtained his undergraduate and doctorate degrees from Vanderbilt University.
He also holds a doctorate degree from the University of Tennessee.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VERU INC
4.84% | 24-05-2024 | 7 086 709 ( 4.84% ) | 7 M $ | 31-05-2024 |
Actieve functies van Mitchell Steiner
| Bedrijven | Functie | Begin |
|---|---|---|
| VERU INC. | Algemeen Directeur | 31-10-2016 |
| MEZZION PHARMA CO.,LTD. | Directeur/Bestuurslid | - |
The Female Health Company (UK) Plc
 The Female Health Company (UK) Plc Miscellaneous ManufacturingProducer Manufacturing The Female Health Company (UK) Plc is based in London, UK. Part of Veru, Inc., The Female Health Company (UK) Plc is a British company that manufactures and sells condoms. Founded in 1989. | Directeur/Bestuurslid | 21-11-2016 |
Eerdere bekende functies van Mitchell Steiner
| Bedrijven | Functie | Einde |
|---|---|---|
Aspen Park Pharmaceuticals, Inc.
 Aspen Park Pharmaceuticals, Inc. Medical DistributorsDistribution Services Aspen Park Pharmaceuticals, Inc. operated as a therapeutics company that focused on the development of men’s health therapies for medical diseases and conditions. The company was founded by Harry Fisch and Mitchell Shuster Steiner in July 2014 and was headquartered in New York, NY. | Oprichter | 01-10-2016 |
| OPKO HEALTH, INC. | Corporate Officer/Principal | 01-01-2016 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Algemeen Directeur | - |
| University of Tennessee | Corporate Officer/Principal | 01-01-2004 |
| Vanderbilt University School of Medicine | Corporate Officer/Principal | 01-01-1995 |
Opleiding van Mitchell Steiner
| University of Tennessee | Doctorate Degree |
| Vanderbilt University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| VERU INC. | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| MEZZION PHARMA CO.,LTD. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Aspen Park Pharmaceuticals, Inc.
Aspen Park Pharmaceuticals, Inc. Medical DistributorsDistribution Services Aspen Park Pharmaceuticals, Inc. operated as a therapeutics company that focused on the development of men’s health therapies for medical diseases and conditions. The company was founded by Harry Fisch and Mitchell Shuster Steiner in July 2014 and was headquartered in New York, NY. | Distribution Services |
The Female Health Company (UK) Plc
The Female Health Company (UK) Plc Miscellaneous ManufacturingProducer Manufacturing The Female Health Company (UK) Plc is based in London, UK. Part of Veru, Inc., The Female Health Company (UK) Plc is a British company that manufactures and sells condoms. Founded in 1989. | Producer Manufacturing |
